Your browser doesn't support javascript.
loading
A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).
Lamont, J P; Nemunaitis, J; Kuhn, J A; Landers, S A; McCarty, T M.
Affiliation
  • Lamont JP; Baylor University Medical Center and US Oncology, Dallas, Texas, USA.
Ann Surg Oncol ; 7(8): 588-92, 2000 Sep.
Article in En | MEDLINE | ID: mdl-11005557
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Genetic Therapy / Antineoplastic Combined Chemotherapy Protocols / Adenoviruses, Human / Head and Neck Neoplasms / Neoplasm Recurrence, Local Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Genetic Therapy / Antineoplastic Combined Chemotherapy Protocols / Adenoviruses, Human / Head and Neck Neoplasms / Neoplasm Recurrence, Local Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States